User profiles for Peter D.R. Higgins
Peter DR HigginsProfessor of Gastroenterology, Internal Medicine, University of Michigan Verified email at umich.edu Cited by 27391 |
Epidemiology of constipation in North America: a systematic review
PDR Higgins, JF Johanson - … journal of the American College of …, 2004 - journals.lww.com
OBJECTIVE The aim of this study was to systematically review the published literature
regarding prevalence, risk factors, incidence, natural history, and the effect on quality of life of …
regarding prevalence, risk factors, incidence, natural history, and the effect on quality of life of …
Statins and cancer prevention
MF Demierre, PDR Higgins, SB Gruber, E Hawk… - Nature Reviews …, 2005 - nature.com
Randomized controlled trials for preventing cardiovascular disease indicated that statins had
provocative and unexpected benefits for reducing colorectal cancer and melanoma. These …
provocative and unexpected benefits for reducing colorectal cancer and melanoma. These …
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to …
GR D'haens, R Panaccione, PDR Higgins… - Official journal of the …, 2011 - journals.lww.com
The advent of biological therapy has revolutionized inflammatory bowel disease (IBD) care.
Nonetheless, not all patients require biological therapy. Selection of patients depends on …
Nonetheless, not all patients require biological therapy. Selection of patients depends on …
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo …
…, M Vandemeulebroecke, W Reinisch, PDR Higgins… - Gut, 2012 - gut.bmj.com
… Pharma; Dr Marc Vandemeulebroecke is an employee of Novartis Pharma and owns Novartis
shares; Dr Walter Reinisch is a medical advisor to Novartis; Dr Peter DR Higgins consults …
shares; Dr Walter Reinisch is a medical advisor to Novartis; Dr Peter DR Higgins consults …
[HTML][HTML] Statins and the risk of colorectal cancer
Background Statins are inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase and
effective lipid-lowering agents. Statins inhibit the growth of colon-cancer cell lines, and …
effective lipid-lowering agents. Statins inhibit the growth of colon-cancer cell lines, and …
[HTML][HTML] A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis
…, A Chak, P Mosler, PDR Higgins… - … England Journal of …, 2012 - Mass Medical Soc
Background Preliminary research suggests that rectally administered nonsteroidal
antiinflammatory drugs may reduce the incidence of pancreatitis after endoscopic retrograde …
antiinflammatory drugs may reduce the incidence of pancreatitis after endoscopic retrograde …
A primer on effectiveness and efficacy trials
… Waljee; critical revision of the manuscript for important intellectual content: Peter DR
Higgins… Rangwalla SC, Waljee AK, Higgins PD. Voting With their Feet (VWF) endpoint: a meta…
Higgins… Rangwalla SC, Waljee AK, Higgins PD. Voting With their Feet (VWF) endpoint: a meta…
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind …
…, G D'Haens, H Nakase, J Panés, PDR Higgins… - The lancet, 2022 - thelancet.com
Background There is a great unmet need for advanced therapies that provide rapid, robust,
and sustained disease control for patients with ulcerative colitis. We assessed the efficacy …
and sustained disease control for patients with ulcerative colitis. We assessed the efficacy …
Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis
… Dr Higgins receives funding for research on inflammatory bowel disease from the National
… Dr Higgins is also the local site investigator at the University of Michigan for industry funded …
… Dr Higgins is also the local site investigator at the University of Michigan for industry funded …
Comparison of imputation methods for missing laboratory data in medicine
Objectives Missing laboratory data is a common issue, but the optimal method of imputation
of missing values has not been determined. The aims of our study were to compare the …
of missing values has not been determined. The aims of our study were to compare the …